Vitamin D3 + K2 – Why Combine Them?
Vitamin D3 K2 is a pairing of two fat-soluble vitamins that has gained increasing attention in the sports nutrition and wellness community. Each has a distinct role in the body, but their functions overlap in a way that makes the combination particularly effective — especially for bone health and cardiovascular support.
In Estonia, situated at roughly 59°N latitude, UVB radiation is insufficient for skin-based vitamin D3 synthesis for approximately five months of the year (October through February). This makes supplementation especially relevant for residents of the Baltic region throughout winter. Even during summer, sunscreen use and indoor lifestyles often prevent sufficient sun-driven D3 production.
What Are Vitamin D3 and K2?
Vitamin D3 (cholecalciferol) is the animal-derived form of vitamin D, produced in the skin upon UVB exposure. In supplements, D3 is preferred over D2 (ergocalciferol) because it raises serum 25(OH)D levels more effectively. Cholecalciferol is chemically identical to what the body makes in the skin, making it the most biologically natural supplemental form.
Vitamin K2 (menaquinone) belongs to the vitamin K family. The most studied subform is MK-7 (menaquinone-7), which stands out for its significantly longer half-life compared to MK-4 — a single daily dose keeps K2 levels stable throughout the day. MK-7 is typically produced via fermentation, similar to the process used to make natto.
These two vitamins share a critical partnership: D3 increases calcium absorption in the intestine, while K2 activates the proteins osteocalcin and Matrix Gla Protein (MGP) that direct calcium into bone and keep it out of arterial walls. Without K2, theoretically high D3 intake could increase calcium absorption without ensuring it ends up in the right place — this is where K2 directly complements D3's role.
Benefits & Research
Bone Health
Knapen et al. (2013) conducted a three-year randomised controlled trial in healthy postmenopausal women and found that low-dose MK-7 supplementation (180 µg/day) helped reduce bone loss at the lumbar spine and femoral neck (Knapen et al., 2013). This remains one of the most cited human trials for K2 MK-7 and bone outcomes.
Vitamin D3's role in bone health is well established. According to NIH ODS, adequate vitamin D is necessary for calcium absorption and bone mineralisation. Low vitamin D status is associated with reduced bone density and increased fracture risk in older adults. Calcium absorption from the gut falls substantially when 25(OH)D serum levels drop below 50 nmol/l.
Cardiovascular Health
Geleijnse et al. (2004) found in the Rotterdam Study that higher dietary intake of menaquinone (K2) was associated with a reduced risk of coronary heart disease, whereas phylloquinone (K1) showed no such association (Geleijnse et al., 2004). The mechanism is thought to involve MGP activation, which inhibits vascular calcification. Arterial calcification is a known risk factor for cardiovascular disease, and K2 may help slow this process through MGP.
Immune Function
Holick (2017) describes how vitamin D receptors (VDR) are present on nearly all immune cells, and that vitamin D deficiency is associated with greater susceptibility to respiratory infections (Holick, 2017). While the immune role of D3 is well supported, the exact clinical magnitude of supplementation effects continues to be studied. This is particularly relevant in the Baltic context, where long winters mean both less sunlight and more time spent in enclosed spaces.
Recommended Dosage
EFSA has set the tolerable upper intake level for vitamin D3 at 100 µg (4000 IU) per day for adults. The general recommended dietary allowance sits at 15 µg (600 IU), though NIH ODS notes that many trials testing health outcomes use 1000–4000 IU daily.
For K2 MK-7, clinical trials typically use 90–180 µg per day. EFSA has not set a specific upper limit for K2, but 90 µg daily is commonly cited as the threshold at which osteocalcin carboxylation becomes measurable. Standard-dose supplements (around 90 µg) are generally well tolerated.
Practical guidance: D3 1000–2000 IU combined with K2 MK-7 90–180 µg per day is a sensible starting point for most adults during winter months. Doses above 4000 IU D3 should be discussed with a healthcare provider.
When to Take D3 + K2
Both vitamins are fat-soluble, so take them with the most fat-containing meal of your day — typically breakfast or lunch — for optimal absorption. Avoid taking on an empty stomach as absorption may be significantly reduced. Some people prefer morning timing since D3 could theoretically influence melatonin pathways when taken late, though the evidence on this is limited.
Signs of Deficiency
Vitamin D deficiency may present as:
- Persistent fatigue and low energy
- Bone pain and muscle weakness
- Frequent infections, particularly respiratory
- Mood changes, especially during darker months
- Slower muscle recovery after training
K2 deficiency is less commonly recognised but prolonged low K2 intake may contribute to arterial calcification and reduced bone strength. Since K2 is found mainly in fermented foods (natto, certain aged cheeses), intake in a typical Estonian diet is often below optimal levels. Many people are unaware they may have low K2 status since it is not routinely tested.
Best Forms
| Vitamin | Preferred form | Why |
|---|---|---|
| D3 | Cholecalciferol | Raises 25(OH)D more effectively than D2 |
| K2 | MK-7 (menaquinone-7) | Longer half-life, more stable blood levels |
Both are fat-soluble — take them with your largest meal of the day for best absorption. Avoid taking on an empty stomach as this can significantly reduce uptake.
Food Sources
Vitamin D3-rich foods: fatty fish (salmon, herring, mackerel), egg yolks, full-fat dairy (in some countries, fortified with D3).
Vitamin K2-rich foods: natto (fermented soybeans — the richest natural K2 source), aged hard cheeses (Gouda, Edam), egg yolks, liver.
Natto is rarely available in Estonian supermarkets. For most people in the Baltics, MK-7 supplements are the most practical way to maintain adequate K2 levels, particularly through the long winter. The same applies to D3 — even in summer, sunscreen and indoor routines often prevent sufficient skin synthesis.
Vitamin D3 K2 Supplements at MaxFit
MaxFit.ee stocks a range of D3+K2 combination products to suit different needs and budgets. OstroVit Vitamin D3 + K2 90 tabs is an affordable everyday option with a standard dose, while OstroVit Pharma D3 4000 IU + K2 MK-7 90 Tabs delivers a higher D3 dose alongside pharmaceutical-grade MK-7 — a good fit for those looking for a premium formulation. BIOTECHUSA Ca-D3-K2 90caps adds calcium to the mix, which may suit those whose dietary calcium intake is consistently low.
Browse the full selection in the vitamin D category.
FAQ
Is taking vitamin D3 K2 together safer than D3 alone?
There is a theoretical rationale: high D3 doses increase calcium absorption, and K2 helps route that calcium into bone rather than arterial walls. This is why many practitioners recommend combining them, particularly when using doses above 2000 IU of D3.
When is the best time to take D3 + K2?
Both vitamins are fat-soluble, so take them with the most fat-containing meal of your day — typically breakfast or lunch — for optimal absorption.
Does vitamin D3 K2 suit vegans?
Most D3 supplements are derived from lanolin (sheep's wool). Vegan-certified D3 sourced from lichen is available — check the label. K2 MK-7 is typically produced via fermentation and is commonly vegan-friendly.
References
Knapen, M. H. J., Drummen, N. E., Smit, E., Vermeer, C., & Theuwissen, E. (2013). Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International, 24(9), 2499–2507.
Geleijnse, J. M., Vermeer, C., Grobbee, D. E., Schurgers, L. J., Knapen, M. H., van der Meer, I. M., Hofman, A., & Witteman, J. C. (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. The Journal of Nutrition, 134(11), 3100–3105.
Holick, M. F. (2017). The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Reviews in Endocrine and Metabolic Disorders, 18(2), 153–165.
